Subscribe

News
Academy
Multimedia
Conferences
Publications
Partner Perspectives
Resources
Subscribe

Brand Insights - Thought Leadership | Paid Program | Deloitte

EP. 1: Are your Therapies Getting to the Patients that Need Them? It May be Time to Reframe your Market Access Strategy.

ByBrian Corvino, Brand Insights Contributor, Managing Director, Deloitte Consulting, LLP and Value, Access, Pricing Practice Leader,John Jaeger, Brand Insights Contributor, Managing Director, Deloitte Consulting LLP

February 28th 2022

EP. 2: Value/Access/Pricing: An essential enabler for delivering on the promise of oncology innovation

ByJoseph M. Coppola, Brand Insights Contributor, Managing Director, Commercial and Market Access Leader, Deloitte Consulting LLP,Brian Corvino, Brand Insights Contributor, Managing Director, Deloitte Consulting, LLP and Value, Access, Pricing Practice Leader

September 20th 2021

EP. 3: Pharmaceutical Product Pricing and Contracts Lifecycle Management: The Importance of Linking Strategy and Operations

ByJoseph M. Coppola, Brand Insights Contributor, Managing Director, Commercial and Market Access Leader, Deloitte Consulting LLP,Brian Corvino, Brand Insights Contributor, Managing Director, Deloitte Consulting, LLP and Value, Access, Pricing Practice Leader

June 12th 2021

EP. 4: The Pandemic Didn’t Hinder Drug Launches, but it Has Altered Sales Tactics

ByBrian Corvino, Brand Insights Contributor, Managing Director, Deloitte Consulting, LLP and Value, Access, Pricing Practice Leader,Candy Lurken, Brand Insights Contributor, Principal, Deloitte Consulting, LLP

May 11th 2021

Trending on PharmExec

JP Morgan 2026 Preview: Roche’s Refresh

FDA Approves Novo Nordisk’s Wegovy Pill for Weight Management

Pharmaceutical Executive Daily: Nine New Additions to TrumpRx

Data Quality in Drug Development: The Missing Foundation to Realize AI’s Promise in Clinical Trials

Pharmaceutical Executive Daily: FDA Approves Wegovy Pill